| Dr Manju D Schorr, MD | |
|
1501 W 24th St, Suite 202, Yuma, AZ 85364-6370 | |
| (602) 249-2490 | |
| (602) 249-2555 |
| Full Name | Dr Manju D Schorr |
|---|---|
| Gender | Female |
| Speciality | Internal Medicine - Endocrinology, Diabetes & Metabolism |
| Location | 1501 W 24th St, Yuma, Arizona |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1972676344 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RE0101X | Internal Medicine - Endocrinology, Diabetes & Metabolism | 31316 (Arizona) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Manju D Schorr, MD 1501 W 24th St, Suite 202, Yuma, AZ 85364-6370 Ph: (602) 249-2490 | Dr Manju D Schorr, MD 1501 W 24th St, Suite 202, Yuma, AZ 85364-6370 Ph: (602) 249-2490 |
News Archive
ImmunoGen, Inc. (NASDAQ: IMGN), a biotechnology company that develops novel anticancer therapeutics using its antibody-drug conjugate (ADC) technology, today announced the first findings from Company research aimed at optimizing the dosing of its IMGN853 product candidate.
Aperio Technologies, Inc., (Aperio), a global leader in digital pathology for the healthcare and life sciences industry, announced today that the United States Patent and Trademark Office has issued the company patent No. 7,457,446 entitled "Fully Automatic Rapid Microscope Slide Scanner."
Methicillin-resistant Staphylococcus aureus (MRSA), an antibiotic-resistant superbug, can cause life-threatening skin, bloodstream and surgical site infections or pneumonia. Researchers at the University of California, San Diego School of Medicine now report that cigarette smoke may make matters worse.
CO2 capture by means of amines is considered to be the most appropriate method to quickly begin with CO2 removal. During this capture process, some of the amines escaping the recycling process will be emitted into the air and will also form other compounds such as nitrosamines and nitramines.
Daiichi Sankyo Company, Limited and ArQule, Inc. today announced that the first patient has been enrolled in the Phase 3 trial of ARQ 197, an investigational selective inhibitor of the c-Met receptor tyrosine kinase, in combination with erlotinib, for patients diagnosed with non-squamous, non-small cell lung cancer (NSCLC) who have received one or two prior systemic anti-cancer therapies.
› Verified 5 days ago
Dr. Augustine W Lau, M.D. Endocrinology, Diabetes & Metabolism Medicare: Medicare Enrolled Practice Location: 2375 S. Ridgeview Drive, Yuma, AZ 85364 Phone: 928-317-2518 Fax: 928-317-1811 | |
Ashvin K Shah, M.D. Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 2110 W 24th St, Yuma, AZ 85364 Phone: 928-344-1891 Fax: 928-726-6306 | |
Aleix M. Bazzi, M.D. Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 2095 W. 24th Street, Suite C, Yuma, AZ 85364 Phone: 928-314-1200 Fax: 928-314-1201 | |
Dr. Vernon Barros Chavez, MD Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 1210 W 24th St, Suite 2, Yuma, AZ 85364 Phone: 928-726-2500 Fax: 928-726-7853 | |
Dr. Julian J. Nicholas, M.D. Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 2400 S Avenue A, Yuma, AZ 85364 Phone: 928-344-2000 | |
Dr. Jeanne Notto Elnadry, M.D. Endocrinology, Diabetes & Metabolism Medicare: Not Enrolled in Medicare Practice Location: 2244 S Avenue A, Suite A, Yuma, AZ 85364 Phone: 928-276-4477 Fax: 928-276-4481 | |
Shahid Mansoor, MD Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 11518 N Frontage Rd Ste A, Yuma, AZ 85367 Phone: 928-342-6500 Fax: 928-342-6863 |